AJO LP’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-22,093
Closed -$2.63M 99
2020
Q4
$2.63M Buy
22,093
+21,331
+2,799% +$2.6M 0.27% 116
2020
Q3
$87K Buy
+762
New +$90K ﹤0.01% 640
2020
Q2
Sell
-34,845
Closed -$2.8M 715
2020
Q1
$2.8M Buy
+34,845
New +$3.61M 0.03% 309
2019
Q1
Sell
-123,101
Closed -$10.3M 678
2018
Q4
$10.3M Sell
123,101
-235,986
-66% -$22.1M 0.06% 224
2018
Q3
$38.7M Sell
359,087
-6,656
-2% -$730K 0.18% 136
2018
Q2
$40.2M Sell
365,743
-13,497
-4% -$1.41M 0.19% 138
2018
Q1
$38M Sell
379,240
-27,940
-7% -$2.86M 0.17% 134
2017
Q4
$40.1M Sell
407,180
-1,646,670
-80% -$156M 0.17% 137
2017
Q3
$192M Sell
2,053,850
-80,395
-4% -$8.53M 0.84% 33
2017
Q2
$237M Buy
2,134,245
+1,237,021
+138% +$131M 1.01% 21
2017
Q1
$88.1M Sell
897,224
-131,008
-13% -$12.5M 0.36% 82
2016
Q4
$94.5M Sell
1,028,232
-655,899
-39% -$56.5M 0.39% 82
2016
Q3
$143M Sell
1,684,131
-21,867
-1% -$1.84M 0.61% 60
2016
Q2
$139M Buy
1,705,998
+467,425
+38% +$35.6M 0.62% 56
2016
Q1
$88.5M Buy
1,238,573
+38,657
+3% +$2.59M 0.38% 83
2015
Q4
$85.4M Buy
1,199,916
+20,475
+2% +$1.38M 0.37% 85
2015
Q3
$72.5M Buy
1,179,441
+47,831
+4% +$3.34M 0.33% 87
2015
Q2
$82.1M Buy
1,131,610
+738,680
+188% +$54.5M 0.35% 93
2015
Q1
$30.2M Buy
+392,930
New +$28.1M 0.13% 131
2014
Q2
Sell
-235,700
Closed -$13.7M 451
2014
Q1
$13.7M Buy
235,700
+50,900
+28% +$2.73M 0.06% 170
2013
Q4
$9.89M Buy
184,800
+121,100
+190% +$7.18M 0.04% 217
2013
Q3
$3.94M Buy
63,700
+54,000
+557% +$3.23M 0.02% 314
2013
Q2
$588K Buy
+9,700
New +$578K ﹤0.01% 456

Other funds holding DGX

AJO LP's DGX Position: Q1 2021 in Review

AJO LP sold out of Quest Diagnostics (DGX) in Q1 2021, closing a stake of 22,093 shares — an estimated $2.63M sold.

AJO LP first reported a position in DGX in Q2 2013 and held it in 23 quarters. The position peaked at $237M in Q2 2017. 817 funds tracked by Wall St. Rank hold DGX as of Q1 2021.

  • AJO LP reported no remaining Quest Diagnostics position as of Q1 2021 after selling out during the quarter.
  • AJO LP sold 22,093 Quest Diagnostics shares in Q1 2021, an estimated $2.63M.
  • AJO LP first reported a position in Quest Diagnostics in Q2 2013 and held it in 23 quarters.
  • AJO LP's Quest Diagnostics position peaked at $237M in Q2 2017.
  • 817 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2021.

Based on AJO LP's 13F filing for Q1 2021, filed 7 May 2021.